Serious adverse events measured by surgery or procedure‐related complications within 30 days ‐ not reported · patients undergoing non‐cardiac surgery/invasive procedures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Surgery‐related complications (during longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes surgery‐related complications (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Non‐surgery‐related complications (during longest · adults receiving intravenous fluids while undergoing major non‐cardiac surgery
It is very uncertain whether perioperative restrictive fluid therapy changes non‐surgery‐related complications (during longest compared with goal‐directed fluid therapy (very low certainty).
1 finding from 1 review
Vomiting · children having undergone thoraco‐lumbar spine surgery. 3 trials included in the analysis contained participants older than 18 years:…
Epidural analgesia showed no clear difference in vomiting up to 48 hours after surgery compared with systemic analgesia (low certainty).
1 finding from 1 review
Postoperative morbidity ‐ sepsis (within 30 days after surgery) · People with localised rectal carcinoma
Preoperative radiotherapy may leads to higher postoperative morbidity ‐ sepsis (within 30 days after surgery) compared with surgery alone (low certainty).
1 finding from 1 review
Postoperative morbidity ‐ surgical complications (within 30 days after surgery) · People with localised rectal carcinoma
Preoperative radiotherapy may leads to higher postoperative morbidity ‐ surgical complications (within 30 days… compared with surgery alone (low certainty).
1 finding from 1 review
All‐cause mortality (within 30‐days after surgery: any reported death) · adults undergoing non‐cardiac surgery
1 finding from 1 review
Acute stroke (within 30‐days after surgery: new focal neurologic deficit with signs and symptoms lasting longer than 24 hours) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists may leads to lower acute stroke (within 30‐days after surgery: new focal neurologic… compared with control (low certainty).
1 finding from 1 review
Cardiac mortality · adults undergoing non‐cardiac surgery
1 finding from 1 review
Myocardial infarction (within 30‐days after surgery: as detected on an electrocardiogram or trans‐oesophageal echocardiogram) · adults undergoing non‐cardiac surgery
1 finding from 1 review
Acute stroke (within 30‐days after surgery: new focal neurologic deficit with signs and symptoms lasting longer than 24 hours) · adults undergoing non‐cardiac surgery
1 finding from 1 review
All‐cause mortality (within 30‐days after surgery: any reported death) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in all‐cause mortality (within 30‐days after surgery: any reported death) compared with control (moderate certainty).
1 finding from 1 review
Cardiac mortality · adults undergoing cardiac surgery
1 finding from 1 review
Myocardial infarction (within 30‐days after surgery: sudden death or death resulting from a primarily identifiable cardiac cause) · adults undergoing cardiac surgery
Alpha‐2 adrenergic agonists showed no clear difference in myocardial infarction (within 30‐days after surgery: sudden death or… compared with control (moderate certainty).
1 finding from 1 review
All‐cause mortality (30 days)—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in all‐cause mortality (30 days)—cardiac surgery compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
Acute myocardial infarction—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in acute myocardial infarction—cardiac surgery compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
Cerebrovascular events—cardiac surgery · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in cerebrovascular events—cardiac surgery compared with control—cardiac surgery (low certainty).
1 finding from 1 review
Ventricular arrhythmias—cardiac surgery ECG · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker probably leads to lower ventricular arrhythmias—cardiac surgery ECG compared with control—cardiac surgery (moderate certainty).
1 finding from 1 review
All supraventricular arrhythmias—cardiac surgery ECG · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker leads to lower all supraventricular arrhythmias—cardiac surgery ECG compared with control—cardiac surgery (high certainty).
1 finding from 1 review
Bradycardia · patients with coronary heart disease and/or valvular heart disease
Beta‐blocker showed no clear difference in bradycardia—cardiac surgery ECG compared with control—cardiac surgery (low certainty).
1 finding from 1 review